Auro-Carvedilol · DIN 02418495 · 3.125 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked November 19, 2026
StatusLimited Use, Reason for Use code 183 required
Write on scriptReason for Use code 183 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Auro-Carvedilol · DIN 02418495
Manufacturer: Auro Pharma Inc.; listing date 2014-04-30
Daily cost (source): $0.4120
Health Canada: Marketed since 2014-02-06 · brand AURO-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Auro pharma inc · schedule Prescription
Auro-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02418495)
Source record
DIN 02418495: Auro-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id AUR
Source form: Tab; strength: 3.125mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02418495
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90306
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060
Carvedilol · DIN 02248752 · $0.2060
Carvedilol · DIN 02364913 · $0.2060
Coreg · DIN 02229650 · not recorded
Jamp-Carvedilol · DIN 02368897 · $0.2060
PMS-Carvedilol · DIN 02245914 · $0.2060
Ran-Carvedilol · DIN 02268027 · $0.2060
Ratio-Carvedilol · DIN 02252309 · $0.2060
Shortage status: not checked (no credentials)